HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Michael J. Shackcloth Joyce Thekkudan Sanjay Ghotkar Walid C. Dihmis Permission Requests Google Scholar Articles by Shackcloth, M. J. Articles by Dihmis, W. C. PubMed Articles by Shackcloth, M. J. Articles by Dihmis, W. C. Related Collections Cardiac - other Great vessels

Attenuation of receptor-dependent and -independent vasoconstriction in the human radial artery

^a The Cardiothoracic Centre, Thomas Drive, Liverpool, UK
^b Department of Human Anatomy & Cell Biology, University of Liverpool, UK

Received 10 January 2008; received in revised form 9 June 2008; accepted 11 June 2008.

^_* Corresponding author. Current address: Physiology Dept, University of Liverpool, Crown St, Liverpool L69 3BX, UK. Tel.: +44 151 7945510; fax: +44 151 7945517. (Email: conant{at}liv.ac.uk).

Background: Vasodilator strategies used to treat bypass grafts in the operating theatre, such as nitrates, phosphodiesterase inhibitors and calcium channel antagonists have a broad but short-lived effect against a variety of vasoconstrictor stimuli. Treatments that react irreversibly with proteins modulating vasoconstriction have the advantage that their effects can last well into the postoperative period. In addition systemic effects are avoided as the treatment is localised to the treated graft. This study investigated the use of two clinically applied drugs; fluphenazine (SKF7171A, HCl), an irreversible calmodulin antagonist and minoxidil sulphate, an irreversible potassium channel opener. Treatments were tested against receptor and non-receptor-mediated contraction in the human radial artery. Method: Isometric tension was measured in response to angiotensin II, KCl and vasopressin in 108 radial artery rings (taken from 31 patients undergoing coronary artery bypass grafting). Control responses were compared with rings pretreated with fluphenazine or minoxidil sulphate. Vasopressin responses were also compared in the presence of glyceryl trinitrate or the reversible Rho kinase inhibitor Y27632. Results: Fluphenazine pretreatment significantly suppressed vasoconstriction to all agonists tested. Maximal responses to angiotensin II, vasopressin and KCl were reduced by 42 ± 19%, 35 ± 8% and 48 ± 15% respectively, without any measurable effect on the EC₅₀. Minoxidil sulphate showed no discernable effect. Vasopressin-induced contraction was also reduced by high levels of glyceryl trinitrate (220 µM; 50 µg/ml) or 10 µM Y27632. Conclusions: The irreversible calmodulin antagonist fluphenazine has potential to be developed as an inhibitor of contraction in arterial graft vessels. The involvement of Rho kinase indicates that other vasoconstrictors and surgical stress can sensitize radial artery to vasopressin-induced contraction. Strategies targeting this pathway also have future potential.

Key Words: Arteries • Artery biochemistry/pharmacology • CABG • Arterial grafts • CABG • Pharmacology/physiology • Cell signaling • Receptors